News

25.11.2016 | List of News

Using thermal measurement to improve cancer therapy outcomes

Model of cancer cells (blue) containing iron oxide nanoparticles (magenta) (© Thomas Moore/AMI)Researchers at the Adolphe Merkle Institute (AMI) at the University of Fribourg, along with colleagues from the Zurich University of Applied Sciences (ZHAW), Winterthur, have developed a novel characterization method, NanoLockin, which can help optimize the design of nanoparticles used in a recent form of cancer therapy known as magnetic hyperthermia.

Magnetic hyperthermia, which relies on iron oxide nanoparticles heated by an alternating magnetic field to kill off tumor cells, has already been authorized in the European Union and implemented notably at Berlin’s famous Charité hospital. Nanoparticles are injected close to the tumor site and then activated by the field. Heat is generated by the particles reacting to the field. If the nanoparticle dosage is right, the tumor is destroyed. Clinical specialists say hyperthermia could be the fourth pillar of cancer treatment, along with surgery, radiotherapy and chemotherapy. However, since the nanoparticle properties are highly dependent on particle and magnetic field properties, optimal dosage remains challenging.

To improve the likelihood of a positive outcome, the AMI researchers, who are specialized in nanoparticle characterization, wanted a method to visualize the behavior of iron oxide particles when heated by a magnetic coil. Current systems rely on fiber optics plunged into a nanoparticle suspension, but this method is less than reliable and suffers from various disadvantages such as low reproducibility, long measurement times and the risk of biased data treatment. They decided instead to use lock-in thermography imaging technology originally developed for the quality control of aircraft parts.      

Faster and more efficient

By using the NanoLockin method, production and dosing of those nanoparticles can be optimized.

“If we want to pursue the development of magnetic hyperthermia, it is extremely important to precisely measure and understand the properties of the nanoparticles you are using,” says AMI NanoLockin project leader Christoph Geers. “With NanoLockin, producers of therapeutic nanoparticles have a tool to easily and precisely control as well as improve their products.”

When nanoparticles are used for cancer therapy for example, this would mean that the particle concentration is the best possible for its target. This also means the treatment would work faster, more successfully and at lower cost.

The scientists at AMI led by the BioNanomaterials group co-chair, Professor Alke Fink, together with ZHAW lecturer Dr. Mathias Bonmarin, developed the Nanolockin system which can precisely measure the distribution and the heat generated by the nanoparticles. Other team members are Christophe Monnier, whose Ph.D. thesis was largely focused on the project, and Ph.D. student Federica Crippa.

The technology developed by the NanoLockin team relies on an alternating magnetic field and infrared imaging to precisely measure the heat produced by the nanoparticles. The results are then evaluated using software specially developed for the system. An algorithm provided by the ZHAW helps specifically determine the nanoparticles’ heating properties based on how they react to the magnetic field.

The other advantage of the measurement system is that there is no contact between the measurements device and the sample, meaning nanoparticles can also be observed in a realistic environment such as tissue samples.

The Swiss Federal Commission for Technology and Innovation has supported the project with funding and further applications of the technology are under development.

For more information, please go to: www.nanolockin.com

Press release in French & German.

Reference & media

Monnier et al., A lock-in-based method to examine the thermal signatures of magnetic nanoparticles in the liquid, solid and aggregated states, Nanoscale, 2016, 8, 13321

Swiss public television SRF, Einstein, January 2016

About the Adolphe Merkle Institute

The Adolphe Merkle Institute (AMI) is an independent competence center at the University of Fribourg that focuses on research and education in the domain of soft nanomaterials. Its research combines fundamental and application-oriented aspects in a multidisciplinary setting. Research there is currently carried out by five research groups: BioNanomaterials, Biophysics, Macromolecular Chemistry, Polymer Chemistry & Materials, and Soft Matter Physics.

ZHAW Zurich University of Applied Sciences

The ZHAW is one of the leading universities of applied sciences in Switzerland. Teaching, research, continuing education and other services are both scientifically-based and practice-oriented. ZHAW graduates are able to apply their knowledge responsibly in demanding professional fields. In its work in research & development, the ZHAW concentrates on important societal challenges, with a particular focus on energy and societal integration. With locations in Winterthur, Zurich and Wädenswil, the ZHAW is firmly integrated in the local region whilst also cooperating with international partners. There are eight Schools in the University: Applied Linguistics, Applied Psychology, Architecture, Design and Civil Engineering, Engineering, Health Professions, Life Sciences and Facility Management, Management and Law, and Social Work.

Contact

Prof. Alke Fink, Co-Chair BioNanomaterials, Adolphe Merkle Institute

Telephone 026 300 95 01 / E-mail (turn on JavaScript)

Dr. Christoph Geers, project leader NanoLockin

Telephone 026 300 85 52 / E-mail (turn on JavaScript)

Dr. Mathias Bonmarin, Institute of Computational Physics (ICP), ZHAW School of Engineering

Telephone 058 934 75 16 / E-mail (turn on JavaScript)

Scott Capper, Communications, Adolphe Merkle Institute

Telephone 026 300 91 20 / E-mail (turn on JavaScript)

Adolphe Merkle Institute - Chemin des Verdiers 4 - CH-1700 Fribourg - Phone +41 26 300 9254